The incidence of inherited porphyrias in Europe

Journal of Inherited Metabolic Disease

Volumn 36, Issue 5, 2013, Pages 849-857

  Elder, George ^a   Harper, Pauline ^b   Badminton, Michael ^a   Sandberg, Sverre ^c   Deybach, Jean Charles ^d  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b KAROLINSKA INSTITUTE   (Sweden)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d HÔPITAL LOUIS MOURIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE INTERMITTENT PORPHYRIA; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; COPROPORPHYRIA; DISEASE SEVERITY; ERYTHROPOIETIC PROTOPORPHYRIA; EUROPE; FEMALE; FRANCE; GENETIC DISORDER; GEOGRAPHIC DISTRIBUTION; HEPATIC PORPHYRIA; HOMOZYGOSITY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; ONSET AGE; POPULATION DIFFERENTIATION; POPULATION RESEARCH; PORPHYRIA; PORPHYRIA VARIEGATA; RECURRENT DISEASE; SEX DIFFERENCE; SWEDEN; SWITZERLAND; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHILD; CHILD, PRESCHOOL; COPROPORPHYRIA, HEREDITARY; EUROPE; FEMALE; HUMANS; INCIDENCE; INFANT; LIVER NEOPLASMS; MALE; MIDDLE AGED; PORPHOBILINOGEN SYNTHASE; PORPHYRIA, ACUTE INTERMITTENT; PORPHYRIA, VARIEGATE; PORPHYRIAS; PORPHYRIAS, HEPATIC; PROSPECTIVE STUDIES; PROTOPORPHYRIA, ERYTHROPOIETIC; YOUNG ADULT;

EID: 84884355114     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-012-9544-4     Document Type: Article

References (42)

1. Aarsand AK, Villanger JH, Støle E, Deybach JC, Marsden J, To-Figueras J, Badminton M, Elder GH, Sandberg S (2011) European specialist porphyria laboratories: diagnostic strategies, analytical quality, clinical interpretation, and reporting as assessed by an external quality assurance program. Clin Chem 57:1514-1523
2. Andant C, Puy H, Bogard C, Faivre J, Soulé JC, Nordmann Y, Deybach JC (2000) Hepatocellular carcinoma in patients with acute hepatic porphyria: frequency of occurrence and related factors. J Hepatol 32:933-939
3. Anderson KE, Sassa SS, Bishop DF, Desnick RJ (2001) X-linked sideroblastic anemia and the porphyrias. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease, 8th edn. McGraw-Hill, New York, pp 2991-3062
4. Andersson C, Bjersing L, Lithner F (1996) The epidemiology of hepatocellular carcinoma in patients with acute intermittent porphyria. J Intern Med 240:195-201
5. Bylesjo I, Wikberg A, Andersson C (2009) Clinical aspects of acute intermittent porphyria in northern Sweden: a population-based study. Scand J Clin Lab Invest 69:612-618
6. Deacon AC, Whatley SD, Elder GH (2006) Porphyrins and disorders of porphyrin metabolism. In: Burtis C, Ashwood ER, Bruns DE (eds) Tietz textbook of clinical chemistry and molecular diagnostics, 4th edn. Elsevier, St Louis, pp 1209-1235
7. Deybach J-C, Puy H (2011) Hepatocellular carcinoma without cirrhosis:think acute hepatic porphyrias or vice versa. J Intern Med 269:521-524
8. Dowman JK, Gunson BK, Mirza DF, Bramhall SR, Badminton MN, Newsome PN, on behalf of the UK Liver Selection and Allocation Working Party (2012) Liver transplantation for acute intermittent porphyria is complicated by a high rate of hepatic artery thrombosis. Liver Transpl 18:195-200
9. Eales L, Day RS, Blekkenhorst GH (1980) The clinical and biochemical features of variegate porphyria: an analysis of 300 cases studied at Groote Schuur Hospital, Cape Town. Int J Biochem 12:837-853
10. Elder GH, Gouya L, Whatley SD, Puy H, Badminton MN, Deybach JC (2009) The molecular genetics of erythropoietic protoporphyria. Cell Mol Biol (Noisy-le-Grand) 55:118-126
11. Floderus Y, Shoolingin-Jordan PM, Harper P (2002) Acute intermittent porphyria in Sweden. Molecular, functional and clinical consequences of some new mutations found in the porphobilinogen deaminase gene. Clin Genet 62:288-297
12. Gouya L, Martin-Schmitt C, Robreau AM, Austerlitz F, Da Silva V, Brun P, Simonin S, Lyoumi S, Grandchamp B, Beaumont C, Puy H, Deybach JC (2006) Contribution of a common single-nucleotide polymorphism to the genetic predisposition for erythropoietic protoporphyria. Am J Hum Genet 78:2-14
13. Hift RJ, Meissner PN (2005) An analysis of 110 acute porphyric attacks in Cape Town, South Africa. Medicine (Baltimore) 84:48-60
14. Hift RJ, Meissner D, Meissner PN (2004) A systematic study of the clinical and biochemical expression of variegate porphyria in a large South African family. Br J Dermatol 151:465-471
15. Holme SA, Anstey AV, Finlay AY, Elder GH, Badminton MN (2006) Erythropoietic protoporphyria in the U.K.: clinical features and effect on quality of life. Br J Dermatol 155:574-581
16. Innala E, Andersson C (2011) Screening for hepatocellular carcinoma in acute intermittent porphyria: a 15-year follow-up in northern Sweden. J Intern Med 269:538-545
17. Kauppinen R, Mustajoki P (1988) Acute hepatic porphyria and hepatocellular carcinoma. Br J Cancer 57:117-120
18. Kauppinen R, Mustajoki P (1992) Prognosis of acute porphyria: occurrence of acute attacks, precipitating factors and associated diseases. Medicine 71:1-13
19. Lamon JM, Frykholm BC, Tschudy DP (1979) Family evaluations in acute intermittent porphyria using red cell uropophyrinogen I synthase. J Med Genet 16:134-139
20. Lithner F, Wetterberg L (1984) Hepatocellular carcinoma in patients with acute intermittent porphyria. Acta Med Scand 215:271-274
21. Martasek P (1998) Hereditary coproporphyria. Semin Liver Dis 18:25-32
22. Meissner PN, Meissner DM, Sturrock ED, Davidson B, Kirsch RE (1987) Porphyria - the UCT experience. South Afr Med J 72:755-61
23. Moore MR, McColl KEL, Rimington C, Goldberg A (1987) Disorders of porphyrin metabolism. Plenum Medical Book Company, New York
24. Murphy GM, Hawk JML, Corbett MF, et al. (1985) The UK erythropietic protoporphyria register: a progress report. Br J Dermatol 113(Supplement 29):11
25. Mustajoki P (1980) Variegate porphyria: 12 years' experience in Finland. Q J Med 49:191-203
26. Mustajoki P, Koskelo P (1976) Hereditary hepatic porphyria in Finland. Acta Med Scand 200:171-178
27. Nordmann Y, Puy H, Da Siva V, Simonin S, Robreau AM, Bonaiti C, Phung LN, Deybach J-C (1997) Acute intermittent porphyria: the prevalence of mutations in the porphobilinogen deaminase gene in blood donors in France. J Int Med 242:213-217
28. Orphanet Report Series (2010) Prevalence of rare diseases; bibliographic data. http://www.orpha.net/orphacom/cahiiers/docs/GB/Prevalence-of-rare- diseases-by-alphabetical-list.pdf
29. Posada de la Paz M, Villaverde-Heuso A, Alonso V, et al. (2010) Rare diseases epidemiology research. In: Posada de la Paz M, Croft SC (eds) Rare diseases epidemiology, Advances in experimental medicine and biology 686. Springer, Dordrecht, pp 17-39
30. Puy H, Gouya L, Deybach J-C (2010) Porphyrias. Lancet 375:924-937
31. Schneider-Yin X, Gouya L, Meier-Weinand A, Deybach JC, Minder EI (2000) New insights into the pathogenesis of erythropoietic protoporphyria and their impact on patient care. Eur J Pediatr 159:719-725
32. Schneider-Yin X, Harms J, Minder EI (2009) Porphyria in Switzerland: 15 years' experience. Swiss Med Wkly 139:198-206
33. Thunell S, Floderus Y, Henrichson A, Harper P (2006) Porphyria in Sweden. Physiol Res 55(Suppl 2):S109-18
34. Todd DJ (1994) Erythropoietic protoporphyria. Brit J Dermatol 131:751-766
35. Ulm K (1990) A simple method to calculate the confidence interval of a standardized mortality ratio(SMR). Amer J Epidem 131:373-375
36. von und zu Fraunberg M, Timonen K, Mustajoki P, et al. (2002) Clinical and biochemical characteristics and genotype-phenotype correlation in Finnish variegate porphyria patients. Eur J Hum Genet 10:649-6
37. von und zu Fraunberg M, Pischik E, Udd L, Kauppinen R (2005) Clinical and biochemical characteristics and genotype-phenotype correlation in 143 Finnish and Russian patients with acute intermittent porphyria. Medicine 84:35-47
38. Wahlin S, Floderus Y, Stål P, Harper P (2011) Erythropoietic protoporphyria in Sweden: clinical and genetic features. J Intern Med 269:278-288
39. Went IN, Klasen EC (1984) Genetic aspects of erythropoietic protoporphyria. Ann Hum Genet 48:105-117
40. Whatley SD, Puy H, Morgan RR, et al. (1999) Variegate porphyria in Western Europe:identification of PPOX gene mutations in 104 families, extent of allelic heterogeneity, and absence of correlation between phenotype and type of mutation. Am J Hum Genet 65:984-994
41. Whatley SD, Mason NG, Holme SA, Anstey AV, Elder GH, Badminton MN (2010) Molecular epidemiology of erythropoietic protoporphyria in the U.K. Br J Dermatol 162:642-646
42. Wiman Å, Floderus Y, Harper P (2003) Novel mutations and phenotypic effect of the splice site modulator IVS3-48C in nine Swedish families with erythropoietic protoporphyria. J Hum Genet 48:70-76